Faeth Therapeutics Inc.
Organization details
- Legal name
- Faeth Therapeutics Inc.
- Former names
- Sensei Biotherapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FTH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001829802
Board of directors
-
Adam Schayowitz · DirectorSince 2026
-
Anand Kiran Parikh · Director · President and CEOSince 2026
-
Bob Holmen · DirectorSince 2023
-
Deneen Vojta · DirectorSince 2023
-
James Peyer · DirectorSince 2023
-
Jessie English · DirectorSince 2023
-
John Celebi · Director · PRESIDENT AND CEOSince 2023
-
Karen H. Vousden · DirectorSince 2026
-
Kristian Humer · DirectorSince 2023
-
Phillip B. Donenberg · DirectorSince 2026
-
Saira Ramasastry · DirectorSince 2026
-
Samuel Broder · DirectorSince 2023
-
Stephen M. Hahn · DirectorSince 2026
-
Thomas G. Ricks · DirectorSince 2023
-
William R. Ringo · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.8%
-
96.9%
Board connections
5 of this board's directors also sit on 7 other boards. 6 are in the same sector.
-
Assembly Biosciences Inc. Same sectorvia William R. Ringo
-
Bristol-Myers Squibb Company Same sectorvia Karen H. Vousden
-
Mirum Pharmaceuticals Inc. Same sectorvia Saira Ramasastry
- via Thomas G. Ricks
-
Taysha Gene Therapies Inc. Same sectorvia Phillip B. Donenberg
-
Tectonic Therapeutic Inc. Same sectorvia Phillip B. Donenberg
-
Vir Biotechnology Inc. Same sectorvia Saira Ramasastry
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,530,465
- 49 purchases by 4 insiders
- Sold, last 12 months
- $2,280,029
- 45 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 30, 2026 | Anand Kiran Parikh Director, Officer (President and CEO) | Gift | −100,000 | — | — |
| Oct 30, 2026 | Anand Kiran Parikh Director, Officer (President and CEO) | Gift | +100,000 | — | — |
| Jul 1, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +4,400 | $23.40 | $102,960 |
| Jul 1, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +600 | $24.22 | $14,532 |
| Jun 30, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +1,910 | $22.95 | $43,835 |
| Jun 30, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +1,638 | $23.88 | $39,115 |
| Jun 30, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +4,255 | $24.98 | $106,290 |
| Jun 29, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +831 | $23.34 | $19,396 |
| Jun 26, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +580 | $23.61 | $13,694 |
| Jun 26, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +4,212 | $24.90 | $104,879 |
| Jun 26, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +1,358 | $25.55 | $34,697 |
| Jun 26, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +100 | $26.39 | $2,639 |
| Jun 24, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +2,891 | $25.22 | $72,911 |
| Jun 24, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +3,000 | $25.98 | $77,940 |
| Jun 24, 2026 | STEPHENSON BRIAN C Officer (Chief Financial Officer) | Open-market purchase | +3,400 | $26.98 | $91,732 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Faeth Therapeutics Inc.
Who is the CEO of Faeth Therapeutics Inc.?
John Celebi is Faeth Therapeutics Inc.'s President and CEO.
How many directors are on Faeth Therapeutics Inc.'s board?
Faeth Therapeutics Inc.'s board has 15 directors: Adam Schayowitz, Anand Kiran Parikh, Bob Holmen, Deneen Vojta, James Peyer, Jessie English, John Celebi, Karen H. Vousden, Kristian Humer, Phillip B. Donenberg and 5 others.
Are Faeth Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Faeth Therapeutics Inc. insiders bought $2.5 million of shares in 49 purchases and sold $2.3 million of shares in 45 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="faeth-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.